Chemours (CC)
NYSE: CC
· Real-Time Price · USD
11.79
-0.20 (-1.67%)
At close: May 13, 2025, 3:59 PM
11.78
-0.04%
After-hours: May 13, 2025, 04:32 PM EDT
Chemours Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2015 |
|---|---|---|---|---|---|---|---|
| Advanced Performance Materials Revenue | 1.33B | 1.44B | 1.62B | 1.4B | 1.1B | 2.35B | 2.39B |
| Advanced Performance Materials Revenue Growth | -8.11% | -10.82% | +15.82% | +26.54% | -52.92% | -2.05% | n/a |
| Thermal And Specialized Solutions Revenue | 1.83B | 1.82B | 1.68B | 1.26B | 1.1B | n/a | n/a |
| Thermal And Specialized Solutions Revenue Growth | +0.60% | +8.27% | +33.65% | +13.76% | n/a | n/a | n/a |
| Titanium Technologies Revenue | 2.57B | 2.68B | 3.38B | 3.35B | 2.4B | n/a | n/a |
| Titanium Technologies Revenue Growth | -4.03% | -20.71% | +0.75% | +39.68% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 123M | 169M | 135M | 139M | 142M | 223M | 165M | 779M | 124M | 175M | 140M | 254M | 141M | 159M | 124M | 172M | 139M | 180M | 112M | 110M | 125M | 125M | 130M | 136M | 156M | 191M | 163M | 161M | 143M | 158M | 148M | 157M | 144M | 480M | 148M | 174M | 133M | 151M | 157M | 157M | 167M |
| Selling, General, and Administrative Revenue Growth | -27.22% | +25.19% | -2.88% | -2.11% | -36.32% | +35.15% | -78.82% | +528.23% | -29.14% | +25.00% | -44.88% | +80.14% | -11.32% | +28.23% | -27.91% | +23.74% | -22.78% | +60.71% | +1.82% | -12.00% | 0.00% | -3.85% | -4.41% | -12.82% | -18.32% | +17.18% | +1.24% | +12.59% | -9.49% | +6.76% | -5.73% | +9.03% | -70.00% | +224.32% | -14.94% | +30.83% | -11.92% | -3.82% | 0.00% | -5.99% | n/a |
| Research and Development Revenue | 27M | 26M | 29M | 26M | 28M | 26M | 28M | 28M | 26M | 30M | 32M | 25M | 30M | 29M | 27M | 27M | 24M | 26M | 22M | 20M | 24M | 19M | 20M | 19M | 22M | 21M | 20M | 20M | 20M | 19M | 20M | 21M | 19M | 20M | 19M | 17M | 23M | 29M | 18M | 27M | 23M |
| Research and Development Revenue Growth | +3.85% | -10.34% | +11.54% | -7.14% | +7.69% | -7.14% | 0.00% | +7.69% | -13.33% | -6.25% | +28.00% | -16.67% | +3.45% | +7.41% | 0.00% | +12.50% | -7.69% | +18.18% | +10.00% | -16.67% | +26.32% | -5.00% | +5.26% | -13.64% | +4.76% | +5.00% | 0.00% | 0.00% | +5.26% | -5.00% | -4.76% | +10.53% | -5.00% | +5.26% | +11.76% | -26.09% | -20.69% | +61.11% | -33.33% | +17.39% | n/a |